Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Longleaf Partners Small-Cap Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+6.85%
Annualized+9.06%
Digest Analysis
Quick Take
"Longleaf Small-Cap outperformed in Q1 with 6.85% return driven by Oscar Health, CNX Resources, and White Mountains. Fund maintains concentrated value approach with 17 holdings trading at mid-60s price-to-value ratio."
Executive Summary
Longleaf Partners Small-Cap Fund returned 6.85% in Q1 2024, outperforming benchmarks despite headwinds for value investing. The fund maintains a concentrated 17-position portfolio focused on companies trading at significant discounts to intrinsic value. Top contributors included Oscar Health, which returned over 60% as its technology platform turned profitable, and CNX Resources, which benefited from operational execution and continued share buybacks despite challenging natural gas prices. White Mountains also contributed strongly as the market recognized strategic positioning. The fund exited Knife River after strong returns and Masonite due to management concerns. Cash increased to 17% as the team maintains discipline in a fully priced market, preferring to wait for compelling opportunities rather than compromise standards. Portfolio companies continue growing value per share while management teams execute intelligent capital allocation. The research team is working on several potential additions to deploy cash when attractive opportunities emerge.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
78%
CautiousHigh
High Conviction (78%)
High conviction evidenced by concentrated 17-position portfolio with named holdings, specific position sizing discussions, and detailed thesis explanations for major positions. Manager explicitly discusses adding to CNX and trimming Oscar/White Mountains based on valuations, demonstrating active conviction-based management.
Growth Outlook
38%
BearishBullish
Neutral (38%)
Manager acknowledges market is fully priced and challenging for finding qualifying ideas, but maintains constructive tone about portfolio companies and research pipeline. Mixed signals with caution about valuations but confidence in holdings.
Risk Appetite
10%
DefensiveAggressive
Defensive (10%)
Portfolio remains concentrated with 17 holdings but cash increased to 17% due to lack of opportunities. Manager trimmed strong performers but added to CNX when discounted. Selective risk-taking within disciplined framework.
Capital Deployment
33%
De-riskingDeploying
De-risking (33%)
Cash increased to 17% from lower levels, representing moderate de-risking. While manager added to CNX position, overall net effect was cash accumulation due to exits and trims exceeding new deployment.
Forward Guidance
15%
CautiousExpansionary
Cautious (15%)
Manager expresses willingness to deploy cash when right opportunities emerge and research team is actively working on several companies. Maintains patient but opportunistic stance for future deployment.
Language Signal
20%
BearishBullish
Bearish (20%)
Language includes positive terms like 'strong performance,' 'solid returns,' 'excited about acquisition,' and 'great opportunistic move' but balanced with caution about 'fully priced market' and 'tough environment.'
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
Manager acknowledges market is fully priced and discusses specific industry risks like natural gas pricing and real estate commission changes. Moderate risk awareness but not alarmed, maintaining disciplined approach.
Opportunity Density
35%
ScarceAbundant
Selective (35%)
Manager explicitly states difficulty finding qualifying ideas in fully priced market, with cash at higher-than-usual 17% level. However, research team is working on several companies, suggesting some opportunities in pipeline.
Time Horizon
72%
Short-TermLong-Term
Decade+ (72%)
Manager focuses on long-term free cash flow growth and value per share, discusses holding through volatility, and emphasizes patient capital approach. Willing to hold cash rather than compromise on standards, indicating multi-year investment horizon.